Recent Posts

Congrats to colleagues, partners & team, with numerous #aao2021 & AUS presentati…

[ad_1] Congrats to colleagues, partners & team, with numerous #aao2021 & AUS presentations on #suprachoroidal delivery, utilizing the SCS Microinjector. Beyond recently FDA-approved #Xipere, 4 clinical trials are now assessing 3 suprachoroidal therapies. #eye #retina #genetherapy https://t.co/25TR3ccT06 [ad_2] Source by Thomas Ciulla, MD, MBA Return 

RT @RetinalPhys: Data Presented From 2 Regenxbio Trials: ALTITUDE and AAVIATE tr…

[ad_1] RT @RetinalPhys: Data Presented From 2 Regenxbio Trials: ALTITUDE and AAVIATE trials promising for subretinal and suprachoroidal delivery o… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @surgeonretina: Nice to see my former @MassEyeAndEar co-resident and now at @…

[ad_1]
RT @surgeonretina: Nice to see my former @MassEyeAndEar co-resident and now at @UCDavisMedCntr @ucdavisvetmed Dr Glenn Yiu presenting on th…
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

VIDEO: Suprachoroidal delivery ‘brings gene therapy into the office setting’ for…

[ad_1] VIDEO: Suprachoroidal delivery ‘brings gene therapy into the office setting’ for wet AMD https://t.co/iK20ZtGrmq [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Latest paper on #Suprachoroidal delivery…. …

[ad_1] Latest paper on #Suprachoroidal delivery…. https://t.co/ZoliOMYTeT [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Recently published: “Glaucoma Heritability: Molecular Mechanisms of Disease”. A …

[ad_1]
Recently published: “Glaucoma Heritability: Molecular Mechanisms of Disease”.
A better understanding of #glaucoma #genetics may enhance detection, treatment, and even contribute to a #genetherapy someday.
#eye #gene #genetics
https://t.co/wI3OGDmvaI #mdpigenes via @Genes_MDPI
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Pleased to co-edit the 2nd of 2 #genetherapy issues of Inter…

[ad_1] RT @ThomasCiullaMD: Pleased to co-edit the 2nd of 2 #genetherapy issues of International Ophthalmology Clinics: https://t.co/a8F5iOhnzM “DN… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: There has been increased interest in #suprachoroidal #geneth…

[ad_1] RT @ThomasCiullaMD: There has been increased interest in #suprachoroidal #genetherapy and our recent paper…. [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @EvolveMedEd: It’s almost time for #AAO21! Have you registered for this CME d…

[ad_1]
RT @EvolveMedEd: It’s almost time for #AAO21! Have you registered for this CME dinner program w/ Drs. Sharma, Srivastava, & Yeh? View more…
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

FDA Approves New Method for Macular Edema Treatment | BioSpace #jobs…

[ad_1] FDA Approves New Method for Macular Edema Treatment | BioSpace https://t.co/7O6CMWHVQL #jobs [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.